Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Omnipod®

M. Heyman

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Omnipod®

J. Okemah

Advancing Type 2 Diabetes Care with Omnipod® 5

Omnipod®

V. Shah, D. Kruger, T. Ly

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Omnipod®

F. Pasquel

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

Tirzepatide Updates

Diana Isaacs

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Type 2 Diabetes Aetiology and Reversibility

Jason Fung

Type 2 Diabetes - Medical Management

Michigan Medicine

A. Rothberg

Unlock the Future of Type 2 Diabetes Care (featuring Dr. Viral Shah)

Omnipod®

V. Shah

Mentor Session: How to Successfully Perform Your First Research Proj…

ISPAD - International Society for Pediatric and Adolescent Diabetes

K. Dovc, T. Biester

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD

Omnipod®

S. Edelman, J. Pettus